Zions Bancorporation, National Association’s Takeda Pharmaceutical TAK Stock Holding History

Zions Bancorporation, National Association’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.94K	Buy	433 +62	+17%	+$1.03K	﹤0.01%	997
2026 Q1	$6.87K	Hold	371	–	–	﹤0.01%	932
2025 Q4	$5.78K	Hold	371	–	–	﹤0.01%	891
2025 Q3	$5.43K	Hold	371	–	–	﹤0.01%	740
2025 Q2	$5.74K	Hold	371	–	–	﹤0.01%	737
2025 Q1	$5.52K	Buy	+371	New	+$5.2K	﹤0.01%	732

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Zions Bancorporation, National Association's TAK Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Takeda Pharmaceutical (TAK) stake by 17% in Q2 2026, buying an estimated $1.03K and bringing the position to 433 shares worth $6.94K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Zions Bancorporation, National Association first reported a position in TAK in Q1 2025 and has held it in 6 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Zions Bancorporation, National Association held 433 shares of Takeda Pharmaceutical worth $6.94K as of Q2 2026.
Zions Bancorporation, National Association bought 62 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.03K.
Takeda Pharmaceutical made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #997 holding.
Zions Bancorporation, National Association first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.